help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frayling, T. M.
Right arrow Articles by Hattersley, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frayling, T. M.
Right arrow Articles by Hattersley, A. T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Diabetes
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 853-857
Copyright © 2000 by The Endocrine Society


Original Studies

No Evidence for Linkage at Candidate Type 2 Diabetes Susceptibility Loci on Chromosomes 12 and 20 in United Kingdom Caucasians

Timothy M. Frayling1, Mark I. McCarthy, Mark Walker, Jonathan C. Levy, Stephen O’Rahilly, Graham A. Hitman, Pamidighantam V. Subba Rao, Amanda J. Bennett, Elizabeth C. Jones, Stephan Menzel, Sian Ellard and Andrew T. Hattersley

Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter (T.M.F., S.E., A.T.H.), EX2 5AX Exeter; the Division of Medicine, Imperial College School of Medicine, St. Mary’s Hospital (M.I.McC.), London; the Department of Medicine, School of Medicine (M.W.), Newcastle-upon-Tyne; Diabetes Research Laboratories, Radcliffe Infirmary (J.C.L.), Oxford; the Departments of Medicine and Clinical Biochemistry, Addenbrooke’s Hospital (S.O.), Cambridge; the Department of Diabetes and Metabolic Medicine, St. Bartholomew’s and the Royal London School of Medicine and Dentistry (G.A.H.), London; and the Wellcome Trust Center for Human Genetics, University of Oxford (P.V.S.R., A.J.B., E.C.J., S.M.), Oxford, United Kingdom

Address all correspondence and requests for reprints to: Dr. T. M. Frayling, Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, Barrack Road, Exeter, United Kingdom EX2 5AX. E-mail: t.m.frayling{at}exeter.ac.uk

Several studies have identified evidence for linkage between type 2 diabetes and the regions on chromosomes 12 and 20 containing the maturity-onset diabetes of the young (MODY) genes, hepatocyte nuclear factor-1{alpha} (HNF-1{alpha}) and HNF-4{alpha}. Two studies examining the HNF-1{alpha} region have demonstrated evidence for linkage at genome-wide levels of significance, whereas four studies examining the HNF-4{alpha} locus have resulted in evidence for linkage at more suggestive levels of significance. The demonstration of linkage to these regions in additional patient series will strengthen the evidence that susceptibility alleles exist at these loci. We therefore assessed the evidence for linkage to these regions using a large cohort of United Kingdom Caucasian type 2 diabetes-affected sibling pairs.

A maximum total of 315 affected full sibling pairs were typed for microsatellite markers across the MODY regions and, in a subset of families, for markers spanning the whole of chromosome 20. Evidence for linkage was assessed using a multipoint, mode of inheritance-free method. Linkage analysis did not reveal any significant evidence for excess allele sharing at any of the regions studied. Loci contributing sibling recurrence risks, relative to the general population risk, of 1.75 and 1.25 could be excluded for the HNF-1{alpha} and HNF-4{alpha} regions, respectively.

We have not confirmed in United Kingdom Caucasians the evidence for linkage previously reported on 12q and 20q. Our results highlight further the problems of replicating previous positive linkage results across different ethnic groups.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. L. Gloyn, F. Reimann, C. Girard, E. L. Edghill, P. Proks, E. R. Pearson, I. K. Temple, D. J.G. Mackay, J. P.H. Shield, D. Freedenberg, et al.
Relapsing diabetes can result from moderately activating mutations in KCNJ11
Hum. Mol. Genet., April 1, 2005; 14(7): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. N. Weedon, K. R. Owen, B. Shields, G. Hitman, M. Walker, M. I. McCarthy, L. D. Love-Gregory, M. A. Permutt, A. T. Hattersley, and T. M. Frayling
Common Variants of the Hepatocyte Nuclear Factor-4{alpha} P2 Promoter Are Associated With Type 2 Diabetes in the U.K. Population
Diabetes, November 1, 2004; 53(11): 3002 - 3006.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J. van Tilburg, T. W van Haeften, P. Pearson, and C. Wijmenga
Defining the genetic contribution of type 2 diabetes mellitus
J. Med. Genet., September 1, 2001; 38(9): 569 - 578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society